Overview

Update
Total Equity Funding
$62M in 2 Rounds from 3 Investors
Most Recent Funding
$56M Series A on November 4, 2015
Headquarters:
San Carlos, CA
Description:
Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.
Founders:
, , , , , ,
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://www.atreca.com

Funding Rounds (4) - $62.86M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2015$56M / Series A3
Aug, 2013$700k / Debt Financing0
Sep, 2012$6M / Venture1
Oct, 2011$160k / Debt Financing0

Current Team (7)

Update

News (4)

Update
DateNews
Nov 4, 2015FinSMEs - Atreca Completes $56M Series A Funding
Sep 23, 2013SEC - SEC FORM D
Sep 15, 2013SEC - SEC FORM D
Sep 25, 2012FinSMEs - FinSMEs

Offices/Locations (1)

Update
  • Office

    75 Shoreway Road, Suite C

    San Carlos, CA 94070-2727

    USA

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos